Impaired Blood Return from the Head, Neck, and Front Legs in Dogs (Cranial Vena Cava Syndrome)
- Synonyms: Cranial vena cava obstruction syndrome, syndrome of the cranial vena cava, obstruction of the cranial vena cava
- Occurrence: very rare
- Location of disease: Chest, Head/Neck, Legs
When to visit the vet?
Urgent see a veterinarian within 24 hours
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Cranial Vena Cava Syndrome is rare in dogs but can be a serious and potentially life-threatening condition. It occurs when blood flow through the cranial vena cava is significantly impeded.
The cranial vena cava transports venous blood from the head, neck, forelegs, and parts of the chest to the right heart. If this blood flow is obstructed, venous pressure increases before the constriction. This characteristically leads to swelling, particularly in the head and neck, which can extend to the chest and forelegs.
The syndrome is not an independent primary disease, but rather a consequence of another illness or a vascular change.
In Cranial Vena Cava Syndrome, blood flow through the cranial vena cava to the right atrium is partially or completely obstructed.
The cause can be an obstruction within the vessel, for example, by a thrombus, an external compression, or the infiltration of a new growth into the vessel.
Due to the impaired venous return, hydrostatic pressure in the afferent veins increases. Fluid leaks into the surrounding tissue, primarily causing edema in the head and neck, as well as the forelegs. Additionally, fluid can accumulate in the chest cavity.
The most important facts at a glance
Cranial Vena Cava Syndrome is rare in dogs but potentially life-threatening. Due to a narrowing or occlusion of the large vein that returns blood from the head, neck, and forelegs to the heart, blood backs up before the constriction. Swelling of the head and neck, which can extend to the chest and forelegs, is particularly typical. Respiratory distress, rapid breathing, weakness, and reduced exercise tolerance often occur.
Causes can include blood clots (thrombosis) or tumors in the chest. If respiratory distress, rapidly increasing swelling, significant weakness, or collapse occurs, the dog must be examined by a veterinarian immediately. Treatment and prognosis largely depend on the underlying cause.
Causes
Key causes include:
- Thrombosis of the cranial vena cava
- Tumors in the anterior mediastinum
- Lymphomas
- Thymomas
- other chest tumors that compress or infiltrate the vein
- inflammatory or infectious masses in the mediastinum
- thrombosis associated with central venous catheters
- thrombosis after implantation of transvenous pacemakers
- severe systemic diseases with increased tendency to thrombosis
Described risk factors for thrombosis of the cranial vena cava include sepsis, immune-mediated diseases, protein-losing nephropathy, tumor diseases, and heart diseases.
Central venous catheters or intravascular pacemaker electrodes can also promote thrombus formation.
Important: Cranial Vena Cava Syndrome should not be equated with the so-called Caval Syndrome in heartworm disease. In Caval Syndrome, numerous heartworms travel retrograde into the right heart and large veins. The pathogenesis and clinical picture differ from the Cranial Vena Cava Syndrome described here.
Symptoms
Therapy
Treatment primarily depends on the cause of the outflow obstruction and the dog’s clinical condition.
In cases of severe respiratory distress or circulatory impairment, stabilization is the priority. Stress should be avoided as much as possible.
If there is a significant pleural effusion, thoracentesis may be necessary to facilitate breathing.
For thrombosis, antithrombotic medications may be considered, depending on the cause, extent, and bleeding risk. Treatment must be determined individually.
If a central venous catheter or pacemaker electrode is involved in the development, it must be checked whether and how the affected system can be removed or modified.
For tumor-related compression or invasion, treatment depends on the type and extent of the tumor. Depending on the findings, surgical removal, chemotherapy, radiation therapy, or palliative measures may be considered.
Individual reports show that surgical treatment may be possible, for example, for operable mediastinal tumors. However, such a decision requires precise imaging assessment.
Prognosis and follow-up care
The prognosis depends crucially on the cause.
With a treatable local cause, significant improvement may be possible. Slowly developing vascular occlusions can sometimes be compensated by the formation of collateral vessels.
In contrast, the prognosis for extensive thrombosis of the cranial vena cava is guarded to poor. In a retrospective study, 15 out of 17 dogs with thrombosis of the cranial vena cava died or were euthanized within 20 days of the onset of clinical symptoms. However, these data come from a small case series and should not be readily transferred to all causes of Cranial Vena Cava Syndrome.
Regular check-ups are required after treatment. Depending on the cause, these may include clinical examinations, ultrasound, echocardiography, CT scans, and monitoring of blood count and coagulation.
Pet owners should particularly watch for recurrent swelling, respiratory distress, reduced exercise tolerance, or weakness.
Prevention
General prevention is not possible, as the syndrome can arise from very different diseases.
However, the risk of thrombosis can be reduced by recognizing and appropriately treating known thrombogenic underlying diseases.
For central venous catheters, it should be regularly checked whether they are still necessary. Catheters no longer needed should be removed.
In dogs with multiple risk factors for thrombosis, it can be individually assessed whether antithrombotic prophylaxis is advisable. Routine prophylactic treatment of every dog with an intravenous catheter is not justified based on current data.
Outlook on current research
Cranial Vena Cava Syndrome is rare in dogs, so veterinary evidence primarily comes from small retrospective case series and individual case reports.
An important area of research is the better identification of dogs at increased risk of thrombosis. This includes, in particular, animals with severe inflammatory conditions or sepsis, protein loss through the kidneys, immune-mediated diseases, tumor diseases, and intravascular catheters or pacemaker electrodes.
Newer imaging techniques, especially CT angiography, allow for increasingly precise visualization of vascular occlusion, tumor invasion, and collateral vessels.
Further studies are needed to determine which dogs benefit from preventive antithrombotic treatment and which therapy provides the best long-term results for existing thrombosis.
Frequently Asked Questions (FAQs)
What is Cranial Vena Cava Syndrome in dogs?
Is Cranial Vena Cava Syndrome common?
Literature
- deLaforcade, A., Bacek, L., Blais, M. C., Goggs, R., Lynch, A., Rozanski, E., & Sharp, C. R. (2022). 2022 update of the consensus on the rational use of antithrombotics and thrombolytics in veterinary critical care (CURATIVE) Domain 1 – Defining populations at risk. Journal of Veterinary Emergency and Critical Care, 32(3), 289–314. https://doi.org/10.1111/vec.13204
- Espino, L., Vazquez, S., Faílde, D., Barreiro, A., Miño, N., & Goicoa, A. (2010). Localized pleural mesothelioma causing cranial vena cava syndrome in a dog. Journal of Veterinary Diagnostic Investigation, 22(2), 309–312. https://doi.org/10.1177/104063871002200228
- Hunt, G. B., Churcher, R. K., Church, D. B., & Mahoney, P. (1997). Excision of a locally invasive thymoma causing cranial vena caval syndrome in a dog. Journal of the American Veterinary Medical Association, 210(11), 1628–1630.
- Mulz, J. M., Kraus, M. S., Thompson, M., & Flanders, J. A. (2010). Cranial vena caval syndrome secondary to central venous obstruction associated with a pacemaker lead in a dog. Journal of Veterinary Cardiology, 12(3), 217–223. https://doi.org/10.1016/j.jvc.2010.09.001
- Palmer, K. G., King, L. G., & Van Winkle, T. J. (1998). Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989–1996). Journal of the American Veterinary Medical Association, 213(2), 220–224.
- Ricciardi, M., & Lanci, M. (2017). Acquired collateral venous pathways in a dog with cranial vena cava obstruction. Journal of Veterinary Medical Science, 79(11), 1772–1775. https://doi.org/10.1292/jvms.17-0283
- Sharp, C. R., Blais, M. C., Boyd, C. J., Brainard, B. M., Chan, D. L., Johnson, A. L., Rozanski, E. A., & deLaforcade, A. M. (2022). 2022 update of the consensus on the rational use of antithrombotics and thrombolytics in veterinary critical care (CURATIVE) Domain 6: Defining rational use of thrombolytics. Journal of Veterinary Emergency and Critical Care, 32(4), 446–470. https://doi.org/10.1111/vec.13227
- Singh, A., & Brisson, B. A. (2010). Chylothorax associated with thrombosis of the cranial vena cava. The Canadian Veterinary Journal, 51(8), 847–852.
- Van De Wiele, C. M., Hogan, D. F., Green, H. W., III, & Parnell, N. K. (2008). Cranial vena caval syndrome secondary to transvenous pacemaker implantation in two dogs. Journal of Veterinary Cardiology, 10(2), 155–161. https://doi.org/10.1016/j.jvc.2008.09.001